DK4093374T3 - Kompleks af 7-deacetylforskolin og PVP - Google Patents

Kompleks af 7-deacetylforskolin og PVP Download PDF

Info

Publication number
DK4093374T3
DK4093374T3 DK21701961.1T DK21701961T DK4093374T3 DK 4093374 T3 DK4093374 T3 DK 4093374T3 DK 21701961 T DK21701961 T DK 21701961T DK 4093374 T3 DK4093374 T3 DK 4093374T3
Authority
DK
Denmark
Prior art keywords
deacetylforskolin
pvp
complex
Prior art date
Application number
DK21701961.1T
Other languages
English (en)
Inventor
Andreas Kubin
Original Assignee
Scipharm Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scipharm Sarl filed Critical Scipharm Sarl
Application granted granted Critical
Publication of DK4093374T3 publication Critical patent/DK4093374T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
DK21701961.1T 2020-01-23 2021-01-22 Kompleks af 7-deacetylforskolin og PVP DK4093374T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20153429 2020-01-23
PCT/EP2021/051499 WO2021148633A1 (de) 2020-01-23 2021-01-22 Komplex aus 7-deacetylforskolin und pvp

Publications (1)

Publication Number Publication Date
DK4093374T3 true DK4093374T3 (da) 2024-02-05

Family

ID=69190714

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21701961.1T DK4093374T3 (da) 2020-01-23 2021-01-22 Kompleks af 7-deacetylforskolin og PVP

Country Status (18)

Country Link
US (1) US20230346956A1 (da)
EP (1) EP4093374B1 (da)
JP (1) JP7700133B2 (da)
AU (1) AU2021211146B2 (da)
BR (1) BR112022014362A2 (da)
CA (1) CA3166464A1 (da)
DK (1) DK4093374T3 (da)
ES (1) ES2969594T3 (da)
FI (1) FI4093374T3 (da)
HR (1) HRP20240181T1 (da)
HU (1) HUE065181T2 (da)
IL (1) IL294848B1 (da)
LT (1) LT4093374T (da)
PL (1) PL4093374T3 (da)
PT (1) PT4093374T (da)
RS (1) RS65265B1 (da)
SI (1) SI4093374T1 (da)
WO (1) WO2021148633A1 (da)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1294205B1 (it) 1997-07-23 1999-03-24 Farmigea Spa Procedimento per la solubilizzazione in acqua e in veicoli acquosi di sostanze farmacologicamente attive
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
JP2007210988A (ja) 2006-02-07 2007-08-23 Sabinsa Corp ジテルペンフォルスコリン及びその誘導体で男性ホルモン及び女性ホルモンを生理学的に増大するための組成物
WO2017103840A1 (en) * 2015-12-16 2017-06-22 MOHAMED ABDULLA ANZAR, Cheppattu A water soluble 10% w/w forskolin composition and a method of synthesizing the same
US11234957B2 (en) * 2017-01-09 2022-02-01 SciPharm S.à.r.l Process for preparing water soluble forskolin

Also Published As

Publication number Publication date
EP4093374B1 (de) 2023-11-15
US20230346956A1 (en) 2023-11-02
HRP20240181T1 (hr) 2024-04-26
AU2021211146B2 (en) 2026-02-12
ES2969594T3 (es) 2024-05-21
RS65265B1 (sr) 2024-03-29
EP4093374A1 (de) 2022-11-30
JP7700133B2 (ja) 2025-06-30
PT4093374T (pt) 2024-01-23
IL294848B1 (en) 2026-01-01
CA3166464A1 (en) 2021-07-29
IL294848A (en) 2022-09-01
BR112022014362A2 (pt) 2022-09-13
SI4093374T1 (sl) 2024-03-29
LT4093374T (lt) 2024-03-12
JP2023511432A (ja) 2023-03-17
HUE065181T2 (hu) 2024-05-28
PL4093374T3 (pl) 2024-04-15
FI4093374T3 (en) 2024-02-06
WO2021148633A1 (de) 2021-07-29
AU2021211146A1 (en) 2022-09-01

Similar Documents

Publication Publication Date Title
DK4161935T3 (da) Brm-målrettende forbindelser og tilhørende anvendelsesmetoder
EP4095671A4 (en) SCREEN VIDEO CAPTURE METHOD AND TERMINAL APPARATUS
EP4472967A4 (en) Iraqi Degradation Agents and Their Uses
DK3595653T3 (da) Sammensætninger af plinabulin og anvendelse heraf
DK4196479T5 (da) Substituerede pyridotriazinforbindelser og anvendelser deraf
IL286481A (en) Pyridazinones and methods of use thereof
DK3823525T3 (da) Måling af perfusion og iltning
EP4499068A4 (en) Iraqi Degradation Agents and Their Uses
EP4024899A4 (en) LOUDSPEAKER AND DEVICE
EP4199540A4 (en) Laser microphone and terminal
DK3710485T3 (da) Anti-sez6-antistof-lægemiddelkonjugater og anvendelsesfremgangsmåder
IL309079A (en) Methods and compositions
DK3707870T3 (da) Gruppering og anvendelse af korte sekvenssignaler
EP4645974A4 (en) POSITIONING METHODS AND POSITIONING APPARATUS
DK4125842T3 (da) Samtidig indgivelse af mirdametinib og lifirafenib til anvendelse til behandling af kræftformer
DK4288426T3 (da) Quinoxalinderivater og anvendelser deraf
EP4198040C0 (de) Pt-dpephos-iod-komplex und pt-dpephos-brom-komplex
EP4244205A4 (en) IRE1ALPHA INHIBITORS AND THEIR USES
DK3651938T3 (da) Fatning og fastgørelse af fatning
DK3383068T3 (da) Automatiseret vurdering og justering af tinnitusmaskerings indvirkning på taleforståelighed under tilpasning
EP4504190A4 (en) OXADIAZOLE HDAC6 INHIBITORS AND THEIR USES
IL312263A (en) Lurbinectedin and atezolizumab combinations
DK4190349T3 (da) Produktion af exosomer og anvendelse heraf
PL4198001T3 (pl) Kompleks Pt-bifenyl-jod i kompleks Pt-bifenyl-brom
EP4197995C0 (de) Pt-xanthen-iod-komplex und pt-xanthen-brom-komplex